Some progress with treatments for CV 19

I reproduce below my recent question pressing for more results on use of drugs for CV 19

Question:
To ask the Secretary of State for Health and Social Care, what the most recent results are of trials of existing approved medicines as potential treatments for covid-19. (81471)

Tabled on: 28 August 2020

Answer:
Jo Churchill:

On 2 September, the World Health Organization (WHO) issued new interim guidance recommending the use of systemic corticosteroids in severe and critical COVID-19 disease. This is based on a meta-analysis of recent clinical trials including the United Kingdom supported REMAP-CAP and RECOVERY trials.

Clinical guidance has been issued recommending clinicians consider the use of systemic corticosteroids, including dexamethasone and hydrocortisone, for National Health Service patients with severe and critical COVID-19.

This updates previous NHS advice to consider dexamethasone for the management of hospitalised patients with COVID-19 who require oxygen or ventilation; the updated advice includes the use of intravenous hydrocortisone and aligns with the WHO guidance.

The NHS advice and WHO guidance can be found at the following links:

The answer was submitted on 15 Sep 2020 at 13:18.